Drugs / Adjuvanted Sabin-IPV
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT01708720 | Aug → Sep 2011 | poliomyelitis | Pauline Verdijk | Completed | No outcome recorded |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT01709071 | Feb → Nov 2012 | poliomyelitis | Pauline Verdijk | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Adjuvanted Sabin-IPV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01708720 ↗ |
| Route | Intramuscular | “Intramuscular injection of 0.5 ml of Inactivated Poliomyelitis Vaccine containing 2.5, 4, 8 D-antigen units respectively of Sabin-1,-2 and -3 per dose adjuvanted with 0.5 mg...” NCT01709071 ↗ |